Author

Zhen Li

China Pharmaceutical UniversityORCID 0009-0004-4853-5706Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Zhen Li10 papers · Beijing National Research Center for Information Science and Technology

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Chris Carrico· 1 shared David J. LeferiD· 1 shared David J. Polhemus· 1 shared Edwin YooiD· 1 shared Jingshu CheniD· 1 shared Joanna ChikweiD· 1 shared Kathleen C. WoulfeiD· 1 shared Mahmoud H. ElbatreekiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Chris Carrico

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Low Dose GLP-1 Therapy Attenuates Pathological Cardiac and Hepatic Remodelling in HFpEF Independent of Weight Loss

Mahmoud H. Elbatreek, Zhen Li, Xiaoman Yu, Natalie Gehred, Tatiana Gromova, Jingshu Chen, Naoto Muraoka, Martin Borch Jensen, Vinay K. Kartha, Chris Carrico, Timothy Daniel Allerton, Michael E. Bowdish, Joanna Chikwe, Sanjiv Jayendra Shah, Kathleen C. Woulfe, , David J. Lefer

This study shows low-dose GLP-1RA therapy improves cardiac and hepatic function in HFpEF without weight loss, through mechanisms like reduced fibrosis and lipid accumulation.

bioRxiv · Sep 26, 2025 · PreprintPharmacology & Toxicology